GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/GI Surgery/Staging Laparoscopy in Gastric Cancer: Surgical Oncology Feb. 2026

Staging Laparoscopy in Gastric Cancer: Surgical Oncology Feb. 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated February 1, 2026

Quick Answer

Introduction Radiographically occult peritoneal carcinomatosis (PC) is a well-recognised challenge in gastric and Siewert III gastroesophageal junction adenocarcinoma. Current guidelines recommend staging laparoscopy (SL) before neoadjuvant systemic therapy (NST) to prevent understaging and inappropriate treatment.


Introduction

Radiographically occult peritoneal carcinomatosis (PC) is a well-recognised challenge in gastric and Siewert III gastroesophageal junction adenocarcinoma. Current guidelines recommend staging laparoscopy (SL) before neoadjuvant systemic therapy (NST) to prevent understaging and inappropriate treatment.

Problem Statement

Despite clear recommendations, real-world adherence to SL remains uncertain. Missing occult peritoneal metastases may expose patients to unnecessary chemotherapy, surgery, and delayed palliative care.

Study Findings

In this multi-institution retrospective analysis of 205 non–stage IV patients (2010–2022), 63% received NST. However, only 29.8% underwent staging laparoscopy before NST. Among those who had SL, 38% were upstaged due to peritoneal metastases—80% with gross PC and 20% with positive cytology.

Among patients proceeding to surgery after NST, recurrence occurred in 33.7%, with the peritoneum as the most common site (38.5%), highlighting the clinical relevance of missed peritoneal disease.

Conclusion

SL is significantly underutilised before NST in gastric cancer. Given that nearly 4 in 10 patients undergoing SL were upstaged, improving compliance is critical. Enhanced adherence to SL—or development of better non-invasive detection strategies—may prevent futile therapy and optimise treatment selection in gastric cancer.

Related Q&A

Mesh Fixation and Chronic Groin Pain: BJS Open | July 2026

Introduction: Chronic postoperative inguinal pain (CPIP) remains one of the most important long-term complications after laparoscopic groin hernia repair, despite lower rates than with open surgery. Whether different mesh types and fixation methods influence the...

Collateral-Based PD Without Venous Reconstruction: Indian J Gastroenterol | July 2026

Introduction: Venous involvement is common in locally advanced pancreatic cancer and often necessitates superior mesenteric-portal vein resection with reconstruction during pancreaticoduodenectomy. However, reconstruction may not always be feasible because of extensive venous disease or unfavorable...

Robotic vs Open Pancreatoduodenectomy: BMJ | July 2026

Introduction: Pancreatoduodenectomy remains one of the most complex abdominal operations. Robotic pancreatoduodenectomy (RPD) has been proposed to improve postoperative recovery, but robust randomized evidence has been limited. The PORTAL trial compared robotic and open pancreatoduodenectomy...

Adapting Military Resilience to Modern Surgery by SOSC: An of Surgery | July 2026

Introduction: Surgery is an inherently high-stress profession, where complications, patient deaths, and difficult decisions can lead to burnout, moral injury, and mental health disorders. Inspired by the US Marine Corps' Combat and Operational Stress Control...

Vascular Resection for Pancreatic Cancer: Annals of Surgery | June 2026

Introduction: As surgical techniques and perioperative therapies have advanced, vascular resection during pancreatic cancer surgery has become increasingly common in selected patients with locally advanced disease. This study evaluated the long-term outcomes of venous and...

Drain Management After Pancreatoduodenectomy: BJS Open | June 2026

Introduction: Optimal drain management after pancreatoduodenectomy (PD) remains critical for preventing postoperative pancreatic fistula (POPF) while supporting enhanced recovery. This study proposes a dynamic, risk-adapted algorithm based on intraoperative risk and postoperative biochemical markers. Why...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer